News Image

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

Provided By GlobeNewswire

Last update: Mar 31, 2025

Successful initial administration and full enrollment in first-in-human LIBERATE-1 study of NPM-115
(exenatide implant) in obese and overweight subjects with top-line data expected in mid-2025

Read more at globenewswire.com

VIVANI MEDICAL INC

NASDAQ:VANI (11/26/2025, 8:07:39 PM)

After market: 1.33 -0.03 (-2.21%)

1.36

+0.04 (+3.03%)



Find more stocks in the Stock Screener

Follow ChartMill for more